SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
latest_posts
- 1
NASA counts down for first crewed lunar mission in half a century - 2Israel says it will keep control over part of southern Lebanon after war with Hezbollah ends
- 3Choosing Moving Styles for Your Restroom Redesign
- 4Defense Minister Katz moves to extend IDF service to 36 months
- 5Figure out What Shift Differentials Mean for Your General Attendant Compensation
- Why the chemtrail conspiracy theory lingers and grows – and why Tucker Carlson is talking about it
- Where America’s CO2 emissions come from – what you need to know, in charts
- NASA unveils close-up pictures of the comet popping by from another star
- Figure out How to Upgrade Your Gold Speculation Portfolio: Vital Bits of knowledge and Strategies
- Smuggler who called migrants 'chickens' jailed
- 13 must-see moon events in 2026: Eclipses, supermoons, conjunctions and more
- Investigating the Advantages of a Bank account: A Complete Aide
- The Force of Mentorship: Self-improvement through Direction
- Arctic sea ice just dropped to an alarming new low
